Identification, synthesis and characterization of avanafil process impurities and determination by UPLC
Avanafil is a phosphodiesterase type 5 inhibitor which is used to treat erectile dysfunction in men. The process-related impurities of avanafil were investigated, and four kinds of impurities in several laboratory batches with a content of 0.29-1.63% were detected by the newly developed gradient ult...
Main Authors: | Jin, Y. (Author), Liu, H. (Author), Liu, Z. (Author), Sun, Y. (Author), Wu, X. (Author), Yu, Z. (Author), Yuan, J. (Author), Zhao, M. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Royal Society of Chemistry
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Improvement of Tests for the Control of Impurities in Antimicrobial Medicinal Products by Chromatographic Methods: Ciprofloxacin Case Study
by: S. I. Kuleshova, et al.
Published: (2018-12-01) -
DEVELOPMENT OF METHODS FOR DETERMINATION OF SPECIFIC IMPURITIES IN THE GLUTATIONION RESTORED SUBSTANCE
by: K. A. Alexeeva, et al.
Published: (2019-01-01) -
Evaluation of impurities in simvastatin drug products with the use of FT-IR spectroscopy and selected chemometric techniques
by: Kupcewicz Bogumiła, et al.
Published: (2013-08-01) -
DETERMINATION OF RELATED IMPURITIES IN THE ANILOCAINE SUBSTANCE BY HPLC METHOD
by: D. R. Sabirzyanov, et al.
Published: (2017-08-01) -
Recent trends in the impurity profile of pharmaceuticals
by: Kavita Pilaniya, et al.
Published: (2010-01-01)